A group of researchers in Japan says its animal experiments have suggested that the Omicron variant of the coronavirus may be less pathogenic than Delta.
The group is led by Associate Professor Sato Kei of the University of Tokyo’s Institute of Medical Science and Professor Fukuhara Takasuke of Hokkaido University’s Graduate School of Medicine.
The research results have been released online.
The group’s studies compared Omicron with the Delta variant and an early pandemic coronavirus.
The group says Delta and the early strain in cell cultures broke up infected cells and induced cell-cell fusions, but Omicron did not show such fusions.
The group also infected hamsters with each of the three viruses.
The researchers say those infected with Delta or the early strain showed weight loss, exacerbation of pneumonia or bleeding in the lung.
By contrast, they say hamsters infected with Omicron did not show such weight change, and their pneumonia did not become serious.
The researchers say the findings about Omicron in their study are just those in an experimental animal model. But they say the results suggest that symptoms of the variant may be milder than Delta and others.
Fukuhara warns people to remain on alert for Omicron as well because it can cause pneumonia and the number of people in serious condition may increase if it spreads.
Mitsubishi launches rocket carrying British satellite
Kyodo – Dec 23
Mitsubishi Heavy Industries Ltd. said Thursday it successfully launched an H-2A rocket carrying a British communications satellite from Tanegashima Space Center in southwestern Japan, with the satellite entering its planned orbit about 26 minutes after liftoff.
Tepco to build underwater tunnel for Fukushima water release
Reuters – Dec 21
The operator of Japan’s crippled Fukushima nuclear power plant intends to build an underwater tunnel to release water from the plant into the sea, it said on Tuesday, as part of a project to treat and dispose of contaminated water.
Is Japan’s Anti Aging Vaccine the Future of Longevity?
AI News – Dec 20
Japan is investing a lot into Longevity Research in hopes of keeping us young forever. And recently, they managed to bring about a new kind of vaccine which manages to stop the aging process very reliably through gene editing and biotechnology.
Japan to approve Moderna vaccine as booster
NHK – Dec 16
Japan’s health ministry is set to approve the use of the Moderna COVID vaccine for third shots. The country has already started giving the Pfizer vaccine as booster shots.
How robotic power suits are helping workers in Japan
CNBC International TV – Dec 14
“The Edge” visits Japanese tech company Atoun and sees how its robotic power suits, which were used by ground staff at the Tokyo Olympic and Paralympic Games, are transforming the way we do manual work.
Leave a Reply